Acyl-CoA:Cholesterol Acyltransferase Inhibition Reduces Atherosclerosis in Apolipoprotein E–Deficient Mice

作者: Jun Kusunoki , Dipal K. Hansoty , Katsumi Aragane , John T. Fallon , Juan J. Badimon

DOI: 10.1161/01.CIR.103.21.2604

关键词:

摘要: Background—Acyl-CoA: cholesterol acyltransferase (ACAT) converts cholesterol to cholesteryl esters. The form of ACAT in macrophages, ACAT1, contributes to foam cell formation in the arterial wall and the development of atherosclerosis. Recent studies in a mouse model of atherosclerosis (the apolipoprotein E [apoE]–deficient mouse), however, have suggested that complete deficiency of ACAT1 activity is not antiatherogenic, in part because of toxicity resulting from adverse effects on tissue cholesterol homeostasis. We …

参考文章(24)
Erling Falk, Prediman K. Shah, Valentin Fuster, Coronary Plaque Disruption Circulation. ,vol. 92, pp. 657- 671 ,(1995) , 10.1161/01.CIR.92.3.657
Peter Libby, Yong Jian Geng, Masanori Aikawa, Uwe Schoenbeck, François Mach, Steven K. Clinton, Galina K. Sukhova, Richard T. Lee, Macrophages and atherosclerotic plaque stability Current Opinion in Lipidology. ,vol. 7, pp. 330- 335 ,(1996) , 10.1097/00041433-199610000-00012
Masahiko Matsuo, Futoshi Ito, Akiko Konto, Miho Aketa, Masaaki Tomoi, Kyoichi Shimomura, Effect of FR145237, a novel ACAT inhibitor, on atherogenesis in cholesterol-fed and WHHL rabbits. Evidence for a direct effect on the arterial wall. Biochimica et Biophysica Acta. ,vol. 1259, pp. 254- 260 ,(1995) , 10.1016/0005-2760(95)00178-6
G. Kellner-Weibel, P. G. Yancey, W. G. Jerome, T. Walser, R. P. Mason, M. C. Phillips, G. H. Rothblat, Crystallization of Free Cholesterol in Model Macrophage Foam Cells Arteriosclerosis, Thrombosis, and Vascular Biology. ,vol. 19, pp. 1891- 1898 ,(1999) , 10.1161/01.ATV.19.8.1891
Michel Accad, Steven J. Smith, Dale L. Newland, David A. Sanan, Lloyd E. King, MacRae F. Linton, Sergio Fazio, Robert V. Farese, Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1. Journal of Clinical Investigation. ,vol. 105, pp. 711- 719 ,(2000) , 10.1172/JCI9021
James Shepherd, Stuart M. Cobbe, Ian Ford, Christopher G. Isles, A. Ross Lorimer, Peter W. Macfarlane, James H. McKillop, Christopher J. Packard, Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group The New England Journal of Medicine. ,vol. 333, pp. 1301- 1307 ,(1995) , 10.1056/NEJM199511163332001
Jun Kusunoki, Katsumi Aragane, Tetsuya Kitamine, Hideki Kozono, Kyoko Kano, Kouji Fujinami, Kazuhiro Kojima, Tsuyoshi Chiwata, Yasuo Sekine, Postprandial Hyperlipidemia in Streptozotocin-Induced Diabetic Rats Is Due to Abnormal Increase in Intestinal Acyl Coenzyme A:Cholesterol Acyltransferase Activity Arteriosclerosis, Thrombosis, and Vascular Biology. ,vol. 20, pp. 171- 178 ,(2000) , 10.1161/01.ATV.20.1.171
M S Brown, J L Goldstein, Lipoprotein metabolism in the macrophage: Implications for cholesterol deposition in atherosclerosis Annual Review of Biochemistry. ,vol. 52, pp. 223- 261 ,(1983) , 10.1146/ANNUREV.BI.52.070183.001255
P R Moreno, E Falk, I F Palacios, J B Newell, V Fuster, J T Fallon, Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation. ,vol. 90, pp. 775- 778 ,(1994) , 10.1161/01.CIR.90.2.775